- MTL Cannabis (CSE:MTLC) intends to raise up to C$4 million through a brokered private placement, including participation from insiders and lead agent Centurion One Capital for up to 25 per cent of the financing
- MTL Cannabis is a Canadian company operating three licensed producers and a network of cannabinoid-focused clinics
- MTL Cannabis stock has added 316.67 per cent year-over-year
MTL Cannabis (CSE:MTLC) intends to raise up to C$4 million through a brokered private placement, including participation from insiders and lead agent Centurion One Capital for up to 25 per cent of the financing.
Centurion One is an independent investment banking firm focused on North American growth companies. The firm’s client roster includes Exro Technologies, Cematrix and WELL Health Technologies.
This content has been prepared as part of a partnership with Montreal Cannabis Corp., and is intended for informational purposes only.
Proceeds from the financing, raised under the Listed Issuer Financing Exemption, are destined for capital expenditures, brand-awareness and other marketing activities, with eyes on continuing MTL Cannabis’ recent ascent into profitability.
The company generated net income of C$2.45 million in fiscal 2024 and C$6.83 million in fiscal 2025, while growing revenue from C$65.29 million to C$84.07 million over the period, representing growth of 28.7 per cent, with chief executive officer Michael Perron stating in the fiscal 2025 news release that “we’ve entered a new era at MTL as we move from building the foundation to achieving record-breaking results.”
Financing details
Each unit is priced at C$0.65 and consists of one common share and one-half of one share purchase warrant, with each warrant exercisable for an additional share priced at C$0.98 for three years following the date of issuance.
According to Tuesday’s news release, Centurion One will be able to sell up to an additional C$1.75 million in units for up to 48 hours prior to the closing date, which will be no later than August 22, 2025.
About MTL Cannabis
MTL Cannabis is a Canadian company operating three licensed producers and a network of cannabinoid-focused clinics.
MTL Cannabis stock (CSE:MTLC) last traded at C$0.75. The stock has added 316.67 per cent year-over-year.
Join the discussion: Find out what investors are saying about this Canadian cannabis stock on the Montreal Cannabis Corp. Bullboard and make sure to explore the rest of Stockhouse’s stock forums and message boards.
Stockhouse does not provide investment advice or recommendations. All investment decisions should be made based on your own research and consultation with a registered investment professional. The issuer is solely responsible for the accuracy of the information contained herein. For full disclaimer information, please click here.
